There are many active research projects accessing and applying shared ADNI data. Use the search above to find specific research focuses on the active ADNI investigations. This information is requested annually as a requirement for data access.
| Principal Investigator | |
| Principal Investigator's Name: | Matthieu Vanhoutte |
| Institution: | INSERM |
| Department: | Cyceron |
| Country: | |
| Proposed Analysis: | The idea of the study is to investigate the PET and MRI data of the ADNI for developing neuroimaging analysis methods to understand the prognosis of Alzheimer's Disease. We are also acquiring MRI and PET data. We would like to compare the results with the ADNI data for quality control and validation. |
| Additional Investigators | |
| Investigator's Name: | Brigitte Landeau |
| Proposed Analysis: | Analysis and processing of PET/MRI imaging data as engineer |
| Investigator's Name: | Siya Sherif |
| Proposed Analysis: | Study of the amyloid staging in Azlheimer's disease |
| Investigator's Name: | Salma Bougacha |
| Proposed Analysis: | Analyses on Tau imaging data |
| Investigator's Name: | Elizabeth Kuhn |
| Proposed Analysis: | ADNI was used as an independent cohort of replication. We want to replicate our results on the existing relationships between the subjective cognitive decline (assessed by Ecog from the participant and the study-partner), the cognition (through multiple neuropsychological tests as MMSE, RAVLT, ADAS13) and multimodal neuroimaging data (MRI, FDG-PET and Florbetapir-PET) across the entire clinical continuum of the Alzheimer"s syndrome (Controls, SMD, MCI and Dementia patients). The first study focused on the participant-reported measure of subjective cognitive decline and the second on the study-partner report. |
| Investigator's Name: | Edelweiss Touron |
| Proposed Analysis: | We investigate the brain substrates of subclinical depressive symptoms (assessed by the GDS scale) in cognitively unimpaired elderly using complementary multimodal neuroimaging data (MRI, FDG- and Florbetapir-PET) both in the primary cohort Age-Well (Caen, France) and the replication cohort ADNI |
